{"id":328,"date":"2020-04-08T15:18:55","date_gmt":"2020-04-08T14:18:55","guid":{"rendered":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/?page_id=328"},"modified":"2020-04-09T11:59:29","modified_gmt":"2020-04-09T10:59:29","slug":"mlisanti","status":"publish","type":"page","link":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/","title":{"rendered":"Professor Michael Lisanti"},"content":{"rendered":"\n<div class=\"wp-block-media-text alignwide has-media-on-the-right\" style=\"grid-template-columns:auto 23%\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"180\" height=\"180\" src=\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png\" alt=\"\" class=\"wp-image-230\" srcset=\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png 180w, https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti-150x150.png 150w\" sizes=\"auto, (max-width: 180px) 100vw, 180px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<h2 class=\"wp-block-heading\">Chair in Translational Medicine<\/h2>\n\n\n\n<p class=\"has-medium-font-size\">University of Salford<\/p>\n\n\n\n<p>M.P.Lisanti@salford.ac.uk<\/p>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator\" \/>\n\n\n\n<p>Michael has been an active research scientist for over 30 years, driving research into tumour metabolism and the discovery of novel cancer biomarkers. His current research programme focuses on interactions between the tumour and the host, and repurposing existing drugs as novel cancer therapies.<\/p>\n\n\n\n<hr class=\"wp-block-separator\" \/>\n\n\n\n<p><span style=\"text-decoration: underline\">Current projects<\/span><br>Targetting mitochondria to find bioactive agents against cancer stem cells and bacteria.<br><em>with <a rel=\"noreferrer noopener\" href=\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/jlatimer\" target=\"_blank\">Joe Latimer<\/a><\/em> <em>and<\/em> <em><a href=\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/lgodoymagalhaes\/\">Luma Godoy Magalh\u00e3es<\/a><\/em><\/p>\n\n\n\n<hr class=\"wp-block-separator\" \/>\n\n\n\n<p><span style=\"text-decoration: underline\">Selected works<\/span><br>Fiorillo, M. &#8230; Lisanti, M. P. (2016). <a rel=\"noreferrer noopener\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5032685\/\" target=\"_blank\">Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).<\/a> <em>Aging (Albany, NY)<\/em> <strong>8<\/strong>(8)<br>Ozsvari, B. &#8230; Lisanti, M. P. (2017). <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28978045\" target=\"_blank\" rel=\"noreferrer noopener\">Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast.<\/a> <em>Oncotarget <\/em><strong>8<\/strong>(40)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chair in Translational Medicine University of Salford M.P.Lisanti@salford.ac.uk Michael has been an active research scientist for over 30 years, driving research into tumour metabolism and the discovery of novel cancer biomarkers. His current research programme focuses on interactions between the tumour and the host, and repurposing existing drugs as novel cancer therapies. Current projectsTargetting mitochondria [&hellip;]<\/p>\n","protected":false},"author":193,"featured_media":230,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-328","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Professor Michael Lisanti - SARN | Salford Antibiotics Research Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Professor Michael Lisanti - SARN | Salford Antibiotics Research Network\" \/>\n<meta property=\"og:description\" content=\"Chair in Translational Medicine University of Salford M.P.Lisanti@salford.ac.uk Michael has been an active research scientist for over 30 years, driving research into tumour metabolism and the discovery of novel cancer biomarkers. His current research programme focuses on interactions between the tumour and the host, and repurposing existing drugs as novel cancer therapies. Current projectsTargetting mitochondria [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/\" \/>\n<meta property=\"og:site_name\" content=\"SARN | Salford Antibiotics Research Network\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-09T10:59:29+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png\" \/>\n\t<meta property=\"og:image:width\" content=\"180\" \/>\n\t<meta property=\"og:image:height\" content=\"180\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/\",\"url\":\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/\",\"name\":\"Professor Michael Lisanti - SARN | Salford Antibiotics Research Network\",\"isPartOf\":{\"@id\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png\",\"datePublished\":\"2020-04-08T14:18:55+00:00\",\"dateModified\":\"2020-04-09T10:59:29+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#primaryimage\",\"url\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png\",\"contentUrl\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png\",\"width\":180,\"height\":180,\"caption\":\"Prof Michael Lisanti\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Professor Michael Lisanti\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#website\",\"url\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/\",\"name\":\"SARN | Salford Antibiotics Research Network\",\"description\":\"Salford University Research Hub\",\"publisher\":{\"@id\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#organization\",\"name\":\"SARN | Salford Antibiotics Research Network\",\"url\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/04\/SARN.png\",\"contentUrl\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/04\/SARN.png\",\"width\":1920,\"height\":489,\"caption\":\"SARN | Salford Antibiotics Research Network\"},\"image\":{\"@id\":\"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Professor Michael Lisanti - SARN | Salford Antibiotics Research Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/","og_locale":"en_US","og_type":"article","og_title":"Professor Michael Lisanti - SARN | Salford Antibiotics Research Network","og_description":"Chair in Translational Medicine University of Salford M.P.Lisanti@salford.ac.uk Michael has been an active research scientist for over 30 years, driving research into tumour metabolism and the discovery of novel cancer biomarkers. His current research programme focuses on interactions between the tumour and the host, and repurposing existing drugs as novel cancer therapies. Current projectsTargetting mitochondria [&hellip;]","og_url":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/","og_site_name":"SARN | Salford Antibiotics Research Network","article_modified_time":"2020-04-09T10:59:29+00:00","og_image":[{"width":180,"height":180,"url":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/","url":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/","name":"Professor Michael Lisanti - SARN | Salford Antibiotics Research Network","isPartOf":{"@id":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#website"},"primaryImageOfPage":{"@id":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#primaryimage"},"image":{"@id":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#primaryimage"},"thumbnailUrl":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png","datePublished":"2020-04-08T14:18:55+00:00","dateModified":"2020-04-09T10:59:29+00:00","breadcrumb":{"@id":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#primaryimage","url":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png","contentUrl":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/03\/MLisanti.png","width":180,"height":180,"caption":"Prof Michael Lisanti"},{"@type":"BreadcrumbList","@id":"http:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/mlisanti\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/"},{"@type":"ListItem","position":2,"name":"Professor Michael Lisanti"}]},{"@type":"WebSite","@id":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#website","url":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/","name":"SARN | Salford Antibiotics Research Network","description":"Salford University Research Hub","publisher":{"@id":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#organization","name":"SARN | Salford Antibiotics Research Network","url":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#\/schema\/logo\/image\/","url":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/04\/SARN.png","contentUrl":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-content\/uploads\/sites\/114\/2020\/04\/SARN.png","width":1920,"height":489,"caption":"SARN | Salford Antibiotics Research Network"},"image":{"@id":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/pages\/328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/users\/193"}],"replies":[{"embeddable":true,"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/comments?post=328"}],"version-history":[{"count":4,"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/pages\/328\/revisions"}],"predecessor-version":[{"id":485,"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/pages\/328\/revisions\/485"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/media\/230"}],"wp:attachment":[{"href":"https:\/\/hub.salford.ac.uk\/salford-antibiotics-research-network\/wp-json\/wp\/v2\/media?parent=328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}